Image de couverture de livre

The Long Term Effect of Doxazosin, Finasteride, and Combination Therapy on the Clinical Progression of Benign Prostatic Hyperplasia

Fuente: Redalyc

Enregistré dans:

Détails bibliographiques
Auteur principal:	Raúl Andrés Duarte Palma
Format:	Artículo científico
Langue:	es
Publié:	Sociedad Colombiana de Urología 2011
Sujets:	Medicina
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Doppler Ultrasonography in the Diagnosis of Dogs With Benign Prostatic Hyperplasia and Investigation of the Efficacy of Finasteride in Treatment
par: Burcu Esin, et autres
Publié: (2025)

The Danger of Long‐Term Use of Rauwolfia vomitoria Afzel. (Apocynaceae) Aqueous Root Back Extract for Benign Prostatic Hyperplasia
par: Perpetua Dagadu, et autres
Publié: (2025)

Use of Epilobium parviflorum in the Treatment of Benign Prostatic Hyperplasia in Canines
par: Guillermo Cazzuli, et autres
Publié: (2025)

Reseña de "Tape Fixation: An important Surgical Step to improve Succes Rate of Anti-Incontinence Surgery" Tomasz Rechberger, Konrad Futyma, Katarzyna Jankiewicz
par: Raúl Andrés Duarte Palma
Publié: (2011)

Single‐Cell Sequencing Reveals That CD4+ T Cells Eliminate Senescent Prostate Epithelium to Delay Progression of Benign Prostatic Hyperplasia
par: Zheng Li, et autres
Publié: (2025)

A New, Minimally Invasive Treatment Option for Benign Prostatic Hyperplasia
Publié: (2025)

Efficacy and Safety of Thulium Laser Vaporization of the Prostate: A Transurethral Procedure for Benign Prostatic Hyperplasia
par: Daisuke Gotoh, et autres
Publié: (2025)

Decoding Benign Prostatic Hyperplasia: Insights from Multi‐Fluid Metabolomic Analysis
par: Xiaoyu Xu, et autres
Publié: (2025)

The Mediterranean Diet and Benign Prostatic Hyperplasia: A Pathway to Improved Urinary Health
par: İsa Dağlı, et autres
Publié: (2025)

Inflammation Mediates the Causal Effect of MMP9 on Benign Prostatic Hyperplasia: A Mendelian Randomization Study
par: Yu Cai, et autres
Publié: (2026)

RETRACTION : Benign Prostatic Hyperplasia Wound after Surgical Removal in Subjects on Anticoagulant or Antiplatelet Therapy: A Meta‐Analysis
Publié: (2025)

Association of Escherichia coli Infection and fimh Virulence With Benign Prostatic Hyperplasia in Ghanaian Patients
par: Yvonne Anang, et autres
Publié: (2025)

Prostatic Surgery With Preservation of the Supramonticular Tissue Versus Standard Surgery for Benign Prostatic Hyperplasia: A Systematic Review
par: Giuston Mendoza‐Chuctaya, et autres
Publié: (2025)

Correction to “Preoperative Factors Predicting Poor Therapeutic Efficacy of Holmium Laser Enucleation of the Prostate in Patients With Benign Prostatic Hyperplasia”
Publié: (2024)

Single‐Cell Profiling of Mononuclear Cells Identifies Transcriptomics Signatures Differentiating Prostate Cancer From Benign Prostatic Hyperplasia
par: Kadriia Enikeeva, et autres
Publié: (2025)

Single‐Cell and Spatial Transcriptomics Uncover Immune Dynamics and Cellular Heterogeneity in Benign Prostatic Hyperplasia and Prostate Cancer Transition
par: Yuanyuan Luo, et autres
Publié: (2026)

Hovenia dulcis Honey Suppresses Androgen‐Induced Epithelial–Mesenchymal Transition in Benign Prostatic Hyperplasia
par: Buyun Kim, et autres
Publié: (2025)

Mechanism of Qianlong Shutong Formula in the Treatment of Benign Prostatic Hyperplasia by Regulating Metabolism and Protein Function
par: Ze‐Chao Zhang, et autres
Publié: (2026)

Initial Experience of Contact Laser Vaporization of the Prostate Using the New Type of Fiber for Benign Prostatic Hyperplasia in a Single Institution
par: Fukashi Yamamichi, et autres
Publié: (2024)

Reseña analítica de "Pharmacological Treatment of Benign Prostatic Hyperplasia (Part I): Just a glance"
par: Rosa Más
Publié: (2007)

Androgenic Alopecia Is Associated With More Severe Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
par: Yasar Pazir, et autres
Publié: (2024)

The Impact of Body Mass Index and Benign Prostatic Hyperplasia on Bone Health of Middle‐Aged and Older Men
par: Tzyy‐Ling Chuang, et autres
Publié: (2025)

Comorbid Diabetes Mellitus Contributes to Residual Overactive Bladder After Transurethral Surgery for Benign Prostatic Hyperplasia
par: Koji Miki, et autres
Publié: (2025)

Does Metabolic Syndrome Influence Surgical Success? Outcomes of Transurethral Resection of Prostate and Open Prostatectomy in Large‐Volume Benign Prostate Hyperplasia
par: Mahmut Uğurlu, et autres
Publié: (2025)

Safety and Efficacy of Bipolar Transurethral Vaporization of the Prostate and Bipolar Transurethral Resection of the Prostate in the Management of Large Volume Benign Prostatic Hyperplasia: A Prospective Randomized Study
par: Amr M. Lotfy, et autres
Publié: (2026)

Chemopreventive Potential of Paddy Waste: A Promising Approach Against Benign Prostate Hyperplasia in Spontaneously Hypertensive Rats
par: Azman Seeni, et autres
Publié: (2025)

Portulaca oleracea Extract Ameliorates Testosterone Propionate‐Induced Benign Prostatic Hyperplasia in Male Sprague‐Dawley Rats
par: Young‐Ju Lim, et autres
Publié: (2024)

Transperineal Laser Ablation of Symptomatic Benign Prostatic Hyperplasia With Median‐Lobe Enlargement: A Single‐Center Experience
par: Antonio Ruffo, et autres
Publié: (2026)

Phytochemical Profiling of the Halophyte Artemisia fukudo Makino and Its In Vitro Effects on Androgen‐Related Pathways Associated With Benign Prostatic Hyperplasia and Alopecia
par: Yun Na Kim, et autres
Publié: (2026)

Probenecid and Eugenol Mitigate Testosterone Induced Benign Prostatic Hyperplasia by Targeting Uric Acid‐Induced Inflammation and Pro‐Survival Pathways
par: Nibrass Taher Abdali, et autres
Publié: (2025)

Prescription Trends of Initial Pharmacotherapy for Benign Prostatic Hyperplasia Among Treatment‐Naïve Patients in South Korea: A Retrospective Analysis
par: Yeon Hee Kim, et autres
Publié: (2025)

Efficacy of Serenoa repens Extract Combined With Alfuzosin Versus Alfuzosin Alone in Men With Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Multicenter Randomized Study
par: Giulio Bevilacqua, et autres
Publié: (2025)

Reseña analítica de "Pharmacological Treatment of Benign Prostatic Hyperplasia Part II: a place for herbal drugs, with focus on Saw palmetto"
par: Rosa Más
Publié: (2007)

Clinical Benefit and Safety of Combined Immunotherapy and Targeted Therapy in Prostate Cancer
par: Zeyu Han, et autres
Publié: (2026)

The Effects of Finasteride on Apoptosis, Antioxidants, and Cytokines in Experimental Diabetes Rats
par: Dilek Aksit, et autres
Publié: (2025)

Ripasudil, a Rho Kinase Inhibitor, Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats: Targeting Inflammation, Oxidative Stress and Rho Kinase Pathways.
par: Aljorani, Randa Hisham
Publié: (2025)

Adjustable TransObturator Male System (ATOMS) After Desobstructive Surgery for Benign Prostatic Hyperplasia – Does the Type of Desobstructive Surgery Make a Difference?
par: Leo Federico Stadelmeier, et autres
Publié: (2026)

Efficacy and Safety of Vibegron Add‐On Therapy for Persistent Overactive Bladder Symptoms in Benign Prostatic Hyperplasia Patients With α 1 ‐Blocker Treatment: A Multi‐Center Prospective Randomized Controlled Study ( VATON Study)
par: Masaki Yoshida, et autres
Publié: (2026)

Investigating the Antihyperplastic, Anti‐Inflammatory and Antioxidant Properties of Cucurbita Pepo L. Seed Oil on Testosterone‐ Induced Benign Prostatic Hyperplasia (BPH) in Castrated Rat Model
par: Hajji Noura, et autres
Publié: (2025)

c‐Kit‐Mediated PI3K/AKT and Wnt/β‐Catenin Signaling Drives Resistance to 5α‐Reductase Inhibitors in Benign Prostatic Hyperplasia
par: Jun Zhu, et autres
Publié: (2025)